KPTI - Karyopharm announces preliminary XPOVIO 4Q19 and FY19 revenue January, 13 2020 08:11 AM Karyopharm Therapeutics Inc. Karyopharm Therapeutics (NASDAQ:KPTI) reports 4Q19 XPOVIO net sales in the range of $17M-$18M and $30M-$31M for FY19.More news on: Karyopharm Therapeutics Inc., Healthcare stocks news, Read more ...